These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

796 related articles for article (PubMed ID: 16050919)

  • 61. Clinical correlates of therapeutic response in bipolar disorder.
    Bowden CL
    J Affect Disord; 2001 Dec; 67(1-3):257-65. PubMed ID: 11869775
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Efficacy of newer anticonvulsant medications in bipolar spectrum mood disorders.
    Evins AE
    J Clin Psychiatry; 2003; 64 Suppl 8():9-14. PubMed ID: 12892536
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Prediction of treatment response in acute mania: controlled clinical trials with divalproex].
    Swann AC
    Encephale; 2001; 27(3):277-9. PubMed ID: 11488258
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Novel treatments for bipolar disorder.
    Bowden CL
    Expert Opin Investig Drugs; 2001 Apr; 10(4):661-71. PubMed ID: 11281816
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
    Houston JP; Tohen M; Degenhardt EK; Jamal HH; Liu LL; Ketter TA
    J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Antidepressant properties of anticonvulsant drugs for bipolar disorder.
    Ernst CL; Goldberg JF
    J Clin Psychopharmacol; 2003 Apr; 23(2):182-92. PubMed ID: 12640220
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Maintenance therapies for classic and other forms of bipolar disorder.
    Bowden CL; Lecrubier Y; Bauer M; Goodwin G; Greil W; Sachs G; von Knorring L
    J Affect Disord; 2000 Sep; 59 Suppl 1():S57-S67. PubMed ID: 11121827
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Recurrence in bipolar I disorder: a post hoc analysis excluding relapses in two double-blind maintenance studies.
    Calabrese JR; Goldberg JF; Ketter TA; Suppes T; Frye M; White R; DeVeaugh-Geiss A; Thompson TR
    Biol Psychiatry; 2006 Jun; 59(11):1061-4. PubMed ID: 16769295
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009.
    Yatham LN; Kennedy SH; Schaffer A; Parikh SV; Beaulieu S; O'Donovan C; MacQueen G; McIntyre RS; Sharma V; Ravindran A; Young LT; Young AH; Alda M; Milev R; Vieta E; Calabrese JR; Berk M; Ha K; Kapczinski F
    Bipolar Disord; 2009 May; 11(3):225-55. PubMed ID: 19419382
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Mood state at study entry as predictor of the polarity of relapse in bipolar disorder.
    Calabrese JR; Vieta E; El-Mallakh R; Findling RL; Youngstrom EA; Elhaj O; Gajwani P; Pies R
    Biol Psychiatry; 2004 Dec; 56(12):957-63. PubMed ID: 15601606
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Treatment of bipolar disorder: a systematic review of available data and clinical perspectives.
    Fountoulakis KN; Vieta E
    Int J Neuropsychopharmacol; 2008 Nov; 11(7):999-1029. PubMed ID: 18752718
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Efficacy and safety of lithium and lamotrigine for the maintenance treatment of clinically stable patients with bipolar disorder: A systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials with an enrichment design.
    Oya K; Sakuma K; Esumi S; Hashimoto Y; Hatano M; Matsuda Y; Matsui Y; Miyake N; Nomura I; Okuya M; Iwata N; Kato M; Hashimoto R; Mishima K; Watanabe N; Kishi T
    Neuropsychopharmacol Rep; 2019 Sep; 39(3):241-246. PubMed ID: 31026388
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Rapid cycling bipolar disorder: clinical characteristics and treatment options.
    Coryell W
    CNS Drugs; 2005; 19(7):557-69. PubMed ID: 15984894
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Atypical antipsychotics and mood stabilization in bipolar disorder.
    Brambilla P; Barale F; Soares JC
    Psychopharmacology (Berl); 2003 Apr; 166(4):315-32. PubMed ID: 12607072
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Newer treatment studies for bipolar depression.
    Gao K; Calabrese JR
    Bipolar Disord; 2005; 7 Suppl 5():13-23. PubMed ID: 16225556
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Preventing new episodes of bipolar disorder in adults: Systematic review and meta-analysis of randomized controlled trials.
    Nestsiarovich A; Gaudiot CES; Baldessarini RJ; Vieta E; Zhu Y; Tohen M
    Eur Neuropsychopharmacol; 2022 Jan; 54():75-89. PubMed ID: 34489127
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Valproate.
    Bowden CL
    Bipolar Disord; 2003 Jun; 5(3):189-202. PubMed ID: 12780873
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Non-conventional pharmacological agents for the treatment of bipolar disorder: Α systematic review of the evidence].
    Fountoulakis KN; Balaris D; Nikolaou V; Νimatoudis J
    Psychiatriki; 2016; 27(4):253-263. PubMed ID: 28114089
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Mood stabilizers--past, present and future].
    Sümegi A
    Neuropsychopharmacol Hung; 2008 Mar; 10(1):31-42. PubMed ID: 18771018
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Bipolar depression: management options.
    Malhi GS; Mitchell PB; Salim S
    CNS Drugs; 2003; 17(1):9-25. PubMed ID: 12467490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.